Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating......
Notwithstanding a strong run by the S&P BSE Information Technology (up 60 per cent) and S&P BSE Healthcare (up 22 per cent) indices in 2013, most brokerages are still positive on these two sectors......
Will Wockhardt be the next Ranbaxy? This is being asked in the backdrop of the company being under the scrutiny of both the American and British drug regulators.First came an import alert from the......
Dr Reddy’s Laboratories (DRL) has surged nearly 21% from its closing low of Rs 1,737.60 on March 01, 2013 on the back of increased traction in approvals from the US Food and Drug......
Wockhardt, the pharmacautical major, is expected to join the billion-dollar (Rs 5,400 crore) revenue club by the month-end, with half of this inflow from America, Chairman Habil Khorakiwala said on......